КСЕНПОМА

ਉਤਪਾਦ ਝਲਕ

About КСЕНПОМА

КСЕНПОМА is a prescription medication containing the active ingredient Pomalidomide, used in the treatment of multiple myeloma and mantle cell lymphoma. It is a thalidomide analogue that works by inhibiting the proliferation of cancer cells and inducing apoptosis.

Key Benefits & Uses

• Treatment of multiple myeloma in patients who have received at least two prior therapies, including lenalidomide and bortezomib.
• Treatment of mantle cell lymphoma in patients who have received at least one prior therapy.
• Management of anemia associated with multiple myeloma.

Active Ingredient & Action

Pomalidomide, the active ingredient in КСЕНПОМА, is a potent immunomodulatory agent that interferes with the proliferation of cancer cells by inhibiting the production of tumor necrosis factor-alpha (TNF-alpha) and other pro-inflammatory cytokines. It also induces apoptosis in cancer cells by activating the caspase cascade.

Important Notes

КСЕНПОМА is available only by prescription and should be used under the guidance of a healthcare professional. It is essential to discuss the potential risks and benefits of treatment with your doctor before starting therapy. Common side effects of КСЕНПОМА include fatigue, anemia, thrombocytopenia, and neutropenia. Patients with a history of thrombosis or embolism should be closely monitored while taking КСЕНПОМА.